Efficacy and Safety of Early Exercise Program After Acute DVT for Prevention of Post Thrombotic Syndrome

Overview

  • Study type

    Interventional
  • Study IDs

  • Describes the nature of a clinical study. Types include:

    • Observational study — observes people and measures outcomes without affecting results.
    • Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
    • Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
  • Site IRB
    • Rochester, Minnesota: 15-009222
    Sponsor Protocol Number: 15-009222

About this study

The pupose of this study is to determine the effect of exercise on patients with an acute deep vein thrombosis.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

See eligibility criteria

Inclusion Criteria:

  • Age 18- 90 years
  • Able to participate in supervised exercise if randomized to this group.
  • Diagnosis of acute DVT (within 24-48 hours) and 24 hours of anticoagulation prior to starting the study.

Exclusion Criteria:

  • Recent major surgery or surgical intervention of the lower extremity wit in the last 3 months.
  • Active malignancy, on treatment with chemo or radiation.
  • Unable to do graded treadmill exercise.
  • Unable to comply with keeping log of activity/exercise.
  • Weight > 300 pounds. (weight limit for the air plethysmography chair)
  • Previous history of DVT or PE.
  • On anticoagulation for another purpose (example stroke prevention with atrial fibrillation)

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Robert McBane, M.D.

Contact us for the latest status

Contact information:

Rayya Saadiq D.O.

(507)293-3380

Saadiq.Rayya@mayo.edu

.
CLS-20306918

Mayo Clinic Footer